Bach Ermina, Møller Andreas B, Jørgensen Jens O L, Vendelbo Mikkel H, Jessen Niels, Olesen Jonas F, Pedersen Steen B, Nielsen Thomas S, Møller Niels
Medical Research Laboratories (E.B., A.B.M., J.O.L.J., M.H.V., N.J., J.F.O., S.B.P., N.M.), Clinical Institute, Aarhus University, 8000 Aarhus, Denmark; Department of Endocrinology and Internal Medicine (E.B., A.B.M., J.O.L.J., M.H.V., N.J., J.F.O., S.B.P., N.M.), Aarhus University Hospital, 8000 Aarhus, Denmark; Department of Internal Medicine (E.B.), Viborg Regional Hospital, 8800 Viborg, Denmark; and The Novo Nordisk Foundation Centre for Basic Metabolic Research (T.S.N.), Section on Integrative Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
J Clin Endocrinol Metab. 2015 Feb;100(2):578-86. doi: 10.1210/jc.2014-2489. Epub 2014 Nov 6.
TNF-α generates inflammatory responses and insulin resistance, lipolysis, and protein breakdown. It is unclear whether these changes depend on intact hypothalamo-pituitary stress hormone responses to trigger the release of cortisol and growth hormone.
To define differential effects of TNF-α on glucose, protein, and lipid metabolism in hypopituitary patients (without intact hypothalamo-pituitary axis) and healthy controls.
Randomized, placebo controlled, single-blinded. Setting, Participants, and Intervention: We studied eight hypopituitary (HP) patients and eight matched control subjects [control volunteers (CTR)] twice during 4-h basal and 2-h hyperinsulinemic clamp conditions with isotope dilution during infusion of saline or TNF-α(12 ng/kg/h) for 6 h.
Phenylalanine, urea, palmitate, and glucose fluxes and fat biopsies in basal and clamp periods.
TNF-α infusion significantly increased cortisol and GH levels in CTR but not in HP. TNF-α increased phenylalanine fluxes in both groups, with the increase being significantly greater in CTR, and raised urea flux by 40 % in CTR without any alteration in HP. Endogenous glucose production (EGP) was elevated in CTR compared to HP after TNF-α administration, whereas insulin sensitivity remained similarly unaffected in both groups. TNF-α increased whole body palmitate fluxes and decreased palmitate specific activity in CTR, but not in HP without statistical difference between groups. We did not detect significant effects TNF-α on lipase expression or regulation in fat.
TNF-α increased both urea and amino acid fluxes and EGP significantly more in CTR compared to HP, suggesting that increases in endogenous cortisol and GH release are significant components of the metabolic response to TNF-α.
肿瘤坏死因子-α(TNF-α)可引发炎症反应、胰岛素抵抗、脂肪分解及蛋白质分解。目前尚不清楚这些变化是否依赖于完整的下丘脑-垂体应激激素反应来触发皮质醇和生长激素的释放。
明确TNF-α对垂体功能减退患者(下丘脑-垂体轴不完整)及健康对照者的葡萄糖、蛋白质和脂质代谢的不同影响。
随机、安慰剂对照、单盲。地点、参与者及干预措施:我们在4小时基础状态和2小时高胰岛素钳夹状态下,对8例垂体功能减退(HP)患者和8例匹配的对照受试者[对照志愿者(CTR)]进行了两次研究,在输注生理盐水或TNF-α(12 ng/kg/h)6小时期间采用同位素稀释法。
基础期和钳夹期的苯丙氨酸、尿素、棕榈酸和葡萄糖通量以及脂肪活检。
输注TNF-α后,CTR组的皮质醇和生长激素水平显著升高,而HP组无明显变化。TNF-α使两组的苯丙氨酸通量均增加,CTR组增加更为显著,CTR组的尿素通量增加40%,而HP组无变化。给予TNF-α后,CTR组的内源性葡萄糖生成(EGP)高于HP组,而两组的胰岛素敏感性均未受明显影响。TNF-α使CTR组的全身棕榈酸通量增加,棕榈酸比活性降低,而HP组无此变化,两组间无统计学差异。我们未检测到TNF-α对脂肪中脂肪酶表达或调节的显著影响。
与HP组相比,TNF-α使CTR组的尿素和氨基酸通量以及EGP显著增加,提示内源性皮质醇和生长激素释放增加是对TNF-α代谢反应的重要组成部分。